Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Influenza

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 135 articles:
HTML format



Single Articles


    April 2025
  1. UYEKI TM, Dugan VG, Daskalakis DC
    Baloxavir Treatment to Reduce Influenza Virus Transmission.
    N Engl J Med. 2025;392:1652-1654.
    PubMed    


  2. MONTO AS, Kuhlbusch K, Bernasconi C, Cao B, et al
    Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza.
    N Engl J Med. 2025;392:1582-1593.
    PubMed     Abstract available


    February 2025
  3. WANG JJ, Warkentin TE, Schonborn L, Wheeler MB, et al
    VITT-like Monoclonal Gammopathy of Thrombotic Significance.
    N Engl J Med. 2025 Feb 12. doi: 10.1056/NEJMoa2415930.
    PubMed     Abstract available


    January 2025
  4. HALL VG, Smibert OC, Sullivan SG, Lim C, et al
    Influenza Vaccination Strategies in Patients with Hematologic Cancer.
    N Engl J Med. 2025;392:306-308.
    PubMed    


    December 2024
  5. GARG S, Reinhart K, Couture A, Kniss K, et al
    Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans.
    N Engl J Med. 2024 Dec 31. doi: 10.1056/NEJMoa2414610.
    PubMed     Abstract available


  6. JASSEM AN, Roberts A, Tyson J, Zlosnik JEA, et al
    Critical Illness in an Adolescent with Influenza A(H5N1) Virus Infection.
    N Engl J Med. 2024 Dec 31. doi: 10.1056/NEJMc2415890.
    PubMed    


    October 2024
  7. BLENDON RJ, Blumenthal D, Glied S, Sommers BD, et al
    Critical Health Care Challenges for the Next U.S. President.
    N Engl J Med. 2024;391:e36.
    PubMed    


    September 2024
  8. WALSH EE
    Creeping toward Effective Antiviral Agents for RSV Infection.
    N Engl J Med. 2024;391:1155-1156.
    PubMed    


  9. ZHAO S, Shang Y, Yin Y, Zou Y, et al
    Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus Infection.
    N Engl J Med. 2024;391:1096-1107.
    PubMed     Abstract available



  10. What Exactly Is Long Covid?: ITT Episode 37.
    N Engl J Med. 2024;391:e17.
    PubMed    


  11. TISZA MJ, Hanson BM, Clark JR, Wang L, et al
    Sequencing-Based Detection of Avian Influenza A(H5N1) Virus in Wastewater in Ten Cities.
    N Engl J Med. 2024 Sep 11. doi: 10.1056/NEJMc2405937.
    PubMed    


  12. ROTTER LK
    "Do You Feel Safe at Home?".
    N Engl J Med. 2024;391:785-787.
    PubMed    


  13. WALENSKY RP, Baggett MV, Tran KM, Shepard JO, et al
    Case 27-2024: A 24-Year-Old Man with Pain and Dyspnea.
    N Engl J Med. 2024;391:845-852.
    PubMed    


    August 2024
  14. DAVIS E, Mayer S, Pacilli M
    Academic Medical Center-Public Health Partnerships for Outbreak Response - Collaborating with Underresourced Communities.
    N Engl J Med. 2024;391:679-681.
    PubMed    


  15. HAYES C
    In Pursuit of Polka Dots.
    N Engl J Med. 2024;391:582-583.
    PubMed    


  16. CANDRIAN C, Weissman JS, Tjia J
    SOGI Data Collection - Proceeding, but with Caution.
    N Engl J Med. 2024;391:580-581.
    PubMed    


  17. HALABI S, O'Hara GL
    Preparing for the Next Pandemic - Expanding and Coordinating Global Regulatory Capacity.
    N Engl J Med. 2024;391:484-487.
    PubMed    


  18. MAKARI GJ, Friedman RA
    Collective Trauma and Commemoration - A Moment of Silence, Please.
    N Engl J Med. 2024;391:487-489.
    PubMed    


  19. MIN J
    Studies of Exagamglogene Autotemcel - Age and Place.
    N Engl J Med. 2024;391:571-572.
    PubMed    


  20. MORSE J, Coyle J, Mikesell L, Stoddard B, et al
    Influenza A(H5N1) Virus Infection in Two Dairy Farm Workers in Michigan.
    N Engl J Med. 2024 Aug 7. doi: 10.1056/NEJMc2407264.
    PubMed    


  21. HAMMOND J, Fountaine RJ, Bao W
    Nirmatrelvir for Adult Outpatients with Covid-19. Reply.
    N Engl J Med. 2024;391:478-479.
    PubMed    


  22. SHANG L, Wang Y, Cao B
    Nirmatrelvir for Adult Outpatients with Covid-19.
    N Engl J Med. 2024;391:477-478.
    PubMed    


  23. BLAIS JE
    Nirmatrelvir for Adult Outpatients with Covid-19.
    N Engl J Med. 2024;391:477.
    PubMed    


  24. SHAN D, Zhang G, Du Z
    Nirmatrelvir for Adult Outpatients with Covid-19.
    N Engl J Med. 2024;391:477.
    PubMed    


    July 2024
  25. SINHA MS, Parmet WE, Gonsalves GS
    Deja Vu All Over Again - Refusing to Learn the Lessons of Covid-19.
    N Engl J Med. 2024 Jul 24. doi: 10.1056/NEJMp2406427.
    PubMed    


  26. HAMMOND J, Yunis C, Fountaine RJ, Luscan G, et al
    Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19.
    N Engl J Med. 2024;391:224-234.
    PubMed     Abstract available


  27. MEISSNER HC, Kapogiannis BG, Wolfe DN
    Anticipating the Next Pandemic.
    N Engl J Med. 2024;391:196-199.
    PubMed    


  28. ROSEN CJ
    Viral Variants, Vaccinations, and Long Covid - New Insights.
    N Engl J Med. 2024 Jul 17. doi: 10.1056/NEJMe2407575.
    PubMed    


  29. XIE Y, Choi T, Al-Aly Z
    Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras.
    N Engl J Med. 2024 Jul 17. doi: 10.1056/NEJMoa2403211.
    PubMed     Abstract available


  30. ASSAD Z, Romain AS, Aupiais C, Shum M, et al
    Nirsevimab and Hospitalization for RSV Bronchiolitis.
    N Engl J Med. 2024;391:144-154.
    PubMed     Abstract available


    June 2024

  31. Are We Prepared for Bird Flu?: ITT Episode 32.
    N Engl J Med. 2024;390:e59.
    PubMed    


  32. SAMET JH, El-Bassel N, Winhusen TJ, Jackson RD, et al
    Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.
    N Engl J Med. 2024 Jun 16. doi: 10.1056/NEJMoa2401177.
    PubMed     Abstract available


  33. KAISER F, Morris DH, Wickenhagen A, Mukesh R, et al
    Inactivation of Avian Influenza A(H5N1) Virus in Raw Milk at 63 degrees C and 72 degrees C.
    N Engl J Med. 2024 Jun 14. doi: 10.1056/NEJMc2405488.
    PubMed    


  34. OWUSU-ANSAH S, Green Rodgers P
    Reviving Hearts - Uniting Communities with Lifesaving Bystander CPR.
    N Engl J Med. 2024;390:2040-2041.
    PubMed    


  35. HAMPSHIRE A, Elliott P
    Cognition and Memory after Covid-19 in a Large Community Sample. Reply.
    N Engl J Med. 2024;390:2035.
    PubMed    


  36. XU L, Huang X, Li Y
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034-2035.
    PubMed    


  37. BUONSENSO D
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034.
    PubMed    


    May 2024
  38. HALABI S, Gostin LO, Egbokhare O, Kavanagh MM, et al
    Global Health Law for a Safer and Fairer World.
    N Engl J Med. 2024;390:1925-1931.
    PubMed    


  39. LIN DY, Du Y, Xu Y, Paritala S, et al
    Durability of XBB.1.5 Vaccines against Omicron Subvariants.
    N Engl J Med. 2024 May 29. doi: 10.1056/NEJMc2402779.
    PubMed    


  40. GUAN L, Eisfeld AJ, Pattinson D, Gu C, et al
    Cow's Milk Containing Avian Influenza A(H5N1) Virus - Heat Inactivation and Infectivity in Mice.
    N Engl J Med. 2024 May 24. doi: 10.1056/NEJMc2405495.
    PubMed    


  41. RUBIN EJ, Baden LR, Daskalakis D, Marston H, et al
    Audio Interview: Preparing for a Possible Avian Influenza Outbreak.
    N Engl J Med. 2024 May 22. doi: 10.1056/NEJMe2406224.
    PubMed    


  42. RUBIN EJ, Baden LR, Marrazzo J, Monto A, et al
    Audio Interview: The Current State of Avian Influenza.
    N Engl J Med. 2024 May 20. doi: 10.1056/NEJMe2406223.
    PubMed    


  43. HERBERT C, McManus DD, Soni A
    False Positive Covid-19 Rapid Antigen Tests. Reply.
    N Engl J Med. 2024;390:1836.
    PubMed    


  44. YANG C, Espin E, Tebbutt SJ
    False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:1835-1836.
    PubMed    


  45. SCHUBACH A, Ricotta D, Kittleson MM
    To Preround or Not to Preround.
    N Engl J Med. 2024;390:1824-1826.
    PubMed    


  46. UYEKI TM, Milton S, Abdul Hamid C, Reinoso Webb C, et al
    Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker.
    N Engl J Med. 2024 May 3. doi: 10.1056/NEJMc2405371.
    PubMed    


    April 2024
  47. WANG Y, Hu H, Cao B
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply.
    N Engl J Med. 2024;390:1534-1535.
    PubMed    


  48. SELVI-SABATER P, de la Rubia Orti JE, Urbieta-Sanz E
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:1534.
    PubMed    


  49. MOSER CB, Li JZ, Hughes MD
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:1533-1534.
    PubMed    


  50. GANDHI RT, Hirsch M
    Treating Acute Covid-19 - Final Chapters Still Unwritten.
    N Engl J Med. 2024;390:1234-1236.
    PubMed    


  51. HAMMOND J, Fountaine RJ, Yunis C, Fleishaker D, et al
    Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.
    N Engl J Med. 2024;390:1186-1195.
    PubMed     Abstract available


    March 2024
  52. HSIAO A, Fireman B, Klein NP
    Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply.
    N Engl J Med. 2024;390:1156.
    PubMed    


  53. WOO EJ, Hulse AN
    Recombinant Influenza Vaccine in Adults under 65 Years of Age.
    N Engl J Med. 2024;390:1155-1156.
    PubMed    


  54. HAVIARI S, Massonnaud CR, Dupont A
    Recombinant Influenza Vaccine in Adults under 65 Years of Age.
    N Engl J Med. 2024;390:1155.
    PubMed    


  55. DIEUSSAERT I, Hyung Kim J, Luik S, Seidl C, et al
    RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.
    N Engl J Med. 2024;390:1009-1021.
    PubMed     Abstract available


    February 2024
  56. ELLINGJORD-DALE M, Brunvoll SH, Soraas A
    Prospective Memory Assessment before and after Covid-19.
    N Engl J Med. 2024;390:863-865.
    PubMed    


  57. AL-ALY Z, Rosen CJ
    Long Covid and Impaired Cognition - More Evidence and More Work to Do.
    N Engl J Med. 2024;390:858-860.
    PubMed    


  58. HAMPSHIRE A, Azor A, Atchison C, Trender W, et al
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:806-818.
    PubMed     Abstract available


  59. MONTO AS, Zambon M, Weir JP
    The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines.
    N Engl J Med. 2024 Feb 28. doi: 10.1056/NEJMp2314801.
    PubMed    


  60. BENEZECH S, Khoryati L, Belot A
    More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C. Reply.
    N Engl J Med. 2024;390:771-772.
    PubMed    


  61. FRANCO A, Tremoulet A, Burns JC
    More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C.
    N Engl J Med. 2024;390:771.
    PubMed    


  62. HERBERT C, McManus DD, Soni A
    Persistent False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:764-765.
    PubMed    


    January 2024
  63. MISSET B, Desmecht D, Laterre PF
    Convalescent Plasma for Covid-19-Induced ARDS. Reply.
    N Engl J Med. 2024;390:386.
    PubMed    


  64. CASADEVALL A, Shoham S, Pirofski LA
    Convalescent Plasma for Covid-19-Induced ARDS.
    N Engl J Med. 2024;390:385-386.
    PubMed    


  65. SENEFELD JW, Henderson JP, Joyner MJ
    Convalescent Plasma for Covid-19-Induced ARDS.
    N Engl J Med. 2024;390:385.
    PubMed    


  66. BORGHESI A, Casanova JL
    Convalescent Plasma for Covid-19-Induced ARDS.
    N Engl J Med. 2024;390:384-385.
    PubMed    


  67. CAO B, Wang Y, Lu H, Huang C, et al
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:230-241.
    PubMed     Abstract available


    December 2023
  68. HALASA NB
    RSV Prevention - Breakthroughs and Challenges.
    N Engl J Med. 2023;389:2480-2481.
    PubMed    


  69. DRYSDALE SB, Cathie K, Flamein F, Knuf M, et al
    Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.
    N Engl J Med. 2023;389:2425-2435.
    PubMed     Abstract available



  70. Covid Update: ITT Episode 23.
    N Engl J Med. 2023;389:e52.
    PubMed    


  71. HSIAO A, Yee A, Fireman B, Hansen J, et al
    Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age.
    N Engl J Med. 2023;389:2245-2255.
    PubMed     Abstract available


  72. COHN AC, Hall AJ
    Continued Progress in the Development of Safe and Effective RSV Immunizations.
    N Engl J Med. 2023;389:2289-2290.
    PubMed    


  73. WILSON E, Goswami J, Baqui AH, Doreski PA, et al
    Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
    N Engl J Med. 2023;389:2233-2244.
    PubMed     Abstract available


    November 2023
  74. BENEZECH S, Khoryati L, Cognard J, Netea SA, et al
    Pre-Covid-19, SARS-CoV-2-Negative Multisystem Inflammatory Syndrome in Children.
    N Engl J Med. 2023;389:2105-2107.
    PubMed    


  75. WANG Y, Guo Z, Ye B, Liu L, et al
    Association of SARS-CoV-2 Infection during Early Weeks of Gestation with Situs Inversus.
    N Engl J Med. 2023;389:1722-1724.
    PubMed    


    October 2023
  76. MISSET B, Piagnerelli M, Hoste E, Dardenne N, et al
    Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients.
    N Engl J Med. 2023;389:1590-1600.
    PubMed     Abstract available


  77. BLADH O, Greilert-Norin N, Havervall S, Marking U, et al
    Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.
    N Engl J Med. 2023;389:1626-1628.
    PubMed    


  78. HILLS TE, Lorenzi E, Berry LR, Shyamsundar M, et al
    Simvastatin in Critically Ill Patients with Covid-19.
    N Engl J Med. 2023 Oct 25. doi: 10.1056/NEJMoa2309995.
    PubMed     Abstract available



  79. The Long Haul of Long Covid.
    N Engl J Med. 2023;389:e29.
    PubMed    


  80. ABI-RACHED JM, Brandt AM
    Do Pandemics Ever End?
    N Engl J Med. 2023;389:1349-1351.
    PubMed    


    September 2023
  81. BOULWARE DR, Lindsell CJ, Stewart TG, Hernandez AF, et al
    Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.
    N Engl J Med. 2023;389:1085-1095.
    PubMed     Abstract available


    August 2023
  82. MURRAY EJ, Cowger TL, Hall KT
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff. Reply.
    N Engl J Med. 2023;389:580.
    PubMed    


  83. MARINE JE
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:579.
    PubMed    


  84. LADHANI SN, Andrews N, Ramsay ME
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:579.
    PubMed    


  85. RUSSELL FM, Curtis N, Carlin J
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:578-579.
    PubMed    


  86. KRISCHER JP, Lernmark A, Hagopian WA, Rewers MJ, et al
    SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens.
    N Engl J Med. 2023;389:474-475.
    PubMed    


    July 2023
  87. BECERRA X, Jha A
    Project NextGen - Defeating SARS-CoV-2 and Preparing for the Next Pandemic.
    N Engl J Med. 2023 Jul 26. doi: 10.1056/NEJMp2307867.
    PubMed    


  88. ARBEL R, Sergienko R, Netzer D, Hammerman A, et al
    Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19. Reply.
    N Engl J Med. 2023;389:285-286.
    PubMed    


  89. HOEG TB, Duriseti R, Prasad V
    Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19.
    N Engl J Med. 2023;389:284-285.
    PubMed    


  90. MCCRINDLE BW, Manlhiot C
    More on SARS-CoV-2 Variants and Pediatric Multisystem Inflammatory Syndrome. Reply.
    N Engl J Med. 2023;389:287-288.
    PubMed    


  91. XIA CY, Niu MM, Hu P
    More on SARS-CoV-2 Variants and Pediatric Multisystem Inflammatory Syndrome.
    N Engl J Med. 2023;389:287.
    PubMed    


  92. PITTET LF, Messina NL, Curtis N
    BCG to Protect against Covid-19 in Health Care Workers. Reply.
    N Engl J Med. 2023;389:192.
    PubMed    


  93. BENN CS, Netea MG, Aaby P
    BCG to Protect against Covid-19 in Health Care Workers.
    N Engl J Med. 2023;389:191-192.
    PubMed    


  94. LOPEZ-CAMPOS GH, Valvano MA
    BCG to Protect against Covid-19 in Health Care Workers.
    N Engl J Med. 2023;389:191.
    PubMed    


    June 2023
  95. HALABI S, Wilder R, Gostin LO, Hurtado ML, et al
    Sharing Pathogen Genomic Sequence Data - Toward Effective Pandemic Prevention, Preparedness, and Response.
    N Engl J Med. 2023;388:2401-2404.
    PubMed    


  96. CAO Z, Gao Y, Zhao R
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19. Reply.
    N Engl J Med. 2023;388:2396-2397.
    PubMed    


  97. LI Y
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2396.
    PubMed    


  98. EDWARDS JL
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2395-2396.
    PubMed    


  99. BERGMANN F, Jorda A, Zeitlinger M
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2395.
    PubMed    


  100. LIN DY, Fleming TR
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2395.
    PubMed    


  101. MCGARRY BE, Gandhi AD, Barnett ML
    Covid-19 Surveillance Testing in Nursing Homes. Reply.
    N Engl J Med. 2023;388:2207-2208.
    PubMed    


  102. STALL NM, Kain DC, Johnstone J
    Covid-19 Surveillance Testing in Nursing Homes.
    N Engl J Med. 2023;388:2207.
    PubMed    


  103. DORFMAN D, Berger Z
    Approving Workplace Accommodations for Patients with Long Covid - Advice for Clinicians.
    N Engl J Med. 2023;388:2115-2117.
    PubMed    


  104. NIKOLICH JZ, Rosen CJ
    Toward Comprehensive Care for Long Covid.
    N Engl J Med. 2023;388:2113-2115.
    PubMed    


  105. GOSTIN LO, Gronvall GK
    The Origins of Covid-19 - Why It Matters (and Why It Doesn't).
    N Engl J Med. 2023 Jun 7. doi: 10.1056/NEJMp2305081.
    PubMed    


  106. TSUBOI M, Herbst RS, John T, Kato T, et al
    Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
    N Engl J Med. 2023 Jun 4. doi: 10.1056/NEJMoa2304594.
    PubMed     Abstract available


  107. REIS G, Mills EJ, Glenn JS
    Pegylated Interferon Lambda for Covid-19. Reply.
    N Engl J Med. 2023;388:2108.
    PubMed    


  108. WANG M, Tang L, Huang L
    Pegylated Interferon Lambda for Covid-19.
    N Engl J Med. 2023;388:2107-2108.
    PubMed    


  109. ANDREAKOS E, Tsiodras S
    Pegylated Interferon Lambda for Covid-19.
    N Engl J Med. 2023;388:2107.
    PubMed    


    May 2023
  110. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: The Lasting Effects of Covid-19.
    N Engl J Med. 2023;388:e76.
    PubMed    


  111. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Ending the Covid-19 Emergency.
    N Engl J Med. 2023;388:e72.
    PubMed    


  112. LISCO A, Ortega-Villa AM, Mystakelis H, Anderson MV, et al
    Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years.
    N Engl J Med. 2023;388:1680-1691.
    PubMed     Abstract available


    April 2023
  113. PITTET LF, Messina NL, Orsini F, Moore CL, et al
    Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.
    N Engl J Med. 2023;388:1582-1596.
    PubMed     Abstract available


  114. KARRON RA
    RSV Illness in the Young and the Old - The Beginning of the End?
    N Engl J Med. 2023;388:1522-1524.
    PubMed    


  115. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: When to Get a Second Covid-19 Booster Shot.
    N Engl J Med. 2023;388:e64.
    PubMed    


  116. ADAMS G, Moreno GK, Petros BA, Uddin R, et al
    Viral Lineages in the 2022 RSV Surge in the United States.
    N Engl J Med. 2023;388:1335-1337.
    PubMed    


  117. KAMPMANN B, Madhi SA, Munjal I, Simoes EAF, et al
    Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.
    N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMoa2216480.
    PubMed     Abstract available


  118. MULLER WJ, Madhi SA, Seoane Nunez B, Baca Cots M, et al
    Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.
    N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMc2214773.
    PubMed    


  119. WALSH EE, Perez Marc G, Zareba AM, Falsey AR, et al
    Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
    N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMoa2213836.
    PubMed     Abstract available


    March 2023
  120. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Ending the Covid-19 Public Health Emergency.
    N Engl J Med. 2023;388:e53.
    PubMed    


  121. JABAGI MJ, Bertrand M, Botton J, Le Vu S, et al
    Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.
    N Engl J Med. 2023 Mar 29. doi: 10.1056/NEJMc2302134.
    PubMed    


  122. NEUZIL KM
    An mRNA Influenza Vaccine - Could It Deliver?
    N Engl J Med. 2023;388:1139-1141.
    PubMed    


  123. MCGARRY BE, Gandhi AD, Barnett ML
    Covid-19 Surveillance Testing and Resident Outcomes in Nursing Homes.
    N Engl J Med. 2023;388:1101-1110.
    PubMed     Abstract available


  124. MCCRINDLE BW, Harahsheh AS, Handoko R, Raghuveer G, et al
    SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children.
    N Engl J Med. 2023 Mar 22. doi: 10.1056/NEJMc2215074.
    PubMed    


  125. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: The Future of Covid-19 Research.
    N Engl J Med. 2023;388:e39.
    PubMed    


  126. MANSOUR MK, King JD, Chen ST, Fishman JA, et al
    Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes.
    N Engl J Med. 2023;388:926-937.
    PubMed    


  127. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: The Path Forward for Covid-19 Therapeutics.
    N Engl J Med. 2023;388:e36.
    PubMed    


  128. OFFIT PA
    Bivalent Covid-19 Vaccines. Reply.
    N Engl J Med. 2023;388:10.
    PubMed    


  129. MARKS PW, Califf RM
    Bivalent Covid-19 Vaccines.
    N Engl J Med. 2023;388:10.
    PubMed    


  130. LI D, Duan M, Wang X, Gao P, et al
    Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines.
    N Engl J Med. 2023 Mar 1. doi: 10.1056/NEJMc2216233.
    PubMed    


    February 2023
  131. HUTH L, Schafer L, Almanzar G, Lupoli G, et al
    Immunologic Effect of Bivalent mRNA Booster in Patients Undergoing Hemodialysis.
    N Engl J Med. 2023 Feb 15. doi: 10.1056/NEJMc2216309.
    PubMed    


    January 2023
  132. ZOU J, Kurhade C, Patel S, Kitchin N, et al
    Neutralization of BA.4-BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine.
    N Engl J Med. 2023 Jan 25. doi: 10.1056/NEJMc2214916.
    PubMed    


    September 2021
  133. AMIT S, Gonen T, Regev-Yochay G
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. Reply.
    N Engl J Med. 2021;385.
    PubMed    


  134. JUNG J, Sung H, Kim SH
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
    N Engl J Med. 2021;385.
    PubMed    


  135. JONES DS, Podolsky SH
    Mask Wars.
    N Engl J Med. 2021;385:1159-1161.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.